AI assistant
Sending…
Tyra Biosciences, Inc. — Director's Dealing 2021
Sep 15, 2021
32575_dirs_2021-09-14_8952c63c-d1f1-474f-ac48-dd9aa572e8e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2021-09-14
Reporting Person: Subramony Siddarth (Director)
More from Tyra Biosciences, Inc.
Regulatory Filings
2026
Jun 2
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Mar 4